Atlas Trials

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

Clinical trial NCT05458856 · COMPLETED

Trial details

NCT number
NCT05458856
Sponsor
Ipsen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2022-08-30
Primary completion
2024-07-08
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.